Intertrust Innovator Series: Psychedelic Technology in Health Care

Intertrust Innovator Series: Psychedelic Technology in Health Care

Join us as Dr. Paul Abramson, a UCSF-trained physician with a private concierge medicine practice in San Francisco, presents an inspiring talk about the re-emergence of psychedelic technology in medical care. Dr. Abramson has been involved in the re-introduction of psychedelic medicines into conventional medical care since 1995, a long-term process that has accelerated in recent years with large-scale clinical trials now in process. He was an early innovator in the use of ketamine-assisted therapies for treatment-resistant mood disorders and refractory pain conditions, combining a novel pharmacology and the use of mystical experience to catalyze psychological and neurological change.
Testing
Testing
Currently, Dr. Abramson teaches at UCSF and CPMC, and is a mentor for students at the CIIS Center for Psychedelic Therapies and Research. He is also a former electrical engineer with two degrees from Stanford. Dr. Abramson’s talk will leave you intrigued about the rapidly changing medical climate as it pertains to the psychedelic technology landscape. The talk will be conducted as a fireside chat, moderated by Talal Shamoon, CEO, Intertrust.
Testing
Testing
6:30-8pm
Testing
CANOPY Jackson Square
Testing
Testing